WebApr 10, 2024 · Originating from intrahepatic bile duct epithelial cells, intrahepatic cholangiocarcinoma (ICC) accounts for 10 ~ 15% of primary liver cancer and is second only to hepatocellular carcinoma (HCC) [].Having a hidden onset, ICC is apt to invade perihepatic organs, tissues, nerves, and lymph nodes, and most patients are generally in … WebClinically, history of cirrhosis and elevated AFP strongly favor HCC over cholangiocarcinoma. Bile and steatosis, when present, are helpful hints for the diagnosis of HCC over cholangiocarcinoma, but frequently immunohistochemical markers are required to make a definitive diagnosis.
Biomarkers in Cholangiocarcinoma - AASLD
WebMay 20, 2013 · Two biomarkers, alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) were measured in the serum samples from 56 patients with cholangiocarcinoma and 35 patients with HCC without evidence of liver cirrhosis. … WebMar 1, 2011 · Cholangiocarcinoma (CCA) is a malignant disease of the epithelial cells in the intra- and extrahepatic bile ducts. While still a rare malignant disease, CCA is the second most common primary malignancy of the liver. The incidence is increasing; especially the incidence of intrahepatic CCA (1). fifocnrl
Cholangiocarcinoma (bile duct cancer) - Symptoms and causes
WebCholangio Carcinoma - Johns Hopkins Medicine WebBiomarkers in Cholangiocarcinoma Jorge A. Marrero, M.D., M.S. Cholangiocarcinoma (CCA) is defined anatomically as intrahepatic CCA (iCCA), perihilar CCA, and distal … WebAlpha-Fetoprotein (AFP), a blood test that is used to identify a possible malignancy. Used to diagnose liver cancer, it is also helpful in diagnosing bile duct cancer. Imaging Scans Imaging scans are noninvasive, … fifo civil engineer